Skip to main content

Specialties
Resources for Physicians
Resources for Your Patients

Search Videos and More

search

Channel Categories

Cancer (130)
Cardiology, Heart & Vascular Surgery (5)
Diabetes & Endocrinology (2)
Gastroenterology (8)
Geriatric Medicine (2)
Neurology (5)
Neurosurgery (3)
Obstetrics & Gynecology (7)
Ophthalmology (3)
Orthopaedics (3)
Other Programs (1)
Otolaryngology (2)
Physical Medicine and Rehabilitation (2)
Psychiatry (2)
Pulmonology (4)
Rheumatology (1)
Urology (2)

Types

News (117)
CME Course (2)
Video Asset (11)

Conditions

[A06.4] Amebic liver abscess (1)
[C01] Tongue Cancer (1)
[C14] Throat Cancer (1)
[C18.9] Colorectal Cancer (1)
[C22.0] Liver cell carcinoma (1)
[C22.3] Angiosarcoma of liver (1)
[C22.8] Liver Cancer (3)
[C25.3] Pancreatic Cancer (6)
[C34.90] Lung Cancer (2)
[C43.0] Malignant melanoma of lip (1)
[C43.1] Malignant melanoma of eyelid, including canthus (1)
[C44.90] Skin Cancer (3)
[C50.1] Malignant neoplasm of central portion of breast (1)
[C50.919] Triple-negative Breast Cancer (5)
[C50.91] Malignant neoplasm of breast of unspecified site, female (1)
[C50.9] Malignant neoplasm of breast of unspecified site (1)
[C50] Breast Cancer (7)
[C53.0] Malignant neoplasm of endocervix (1)
[C53.1] Malignant neoplasm of exocervix (1)
[C53.8] Malignant neoplasm of overlapping sites of cervix uteri (1)
[C53.9] Malignant neoplasm of cervix uteri, unspecified (1)
[C53] Malignant neoplasm of cervix uteri (1)
[C61] Prostate Cancer (1)
[C64] Kidney Cancer (1)
[C71.9] Glioblastoma (2)
[C76.0] Head and Neck Cancer (2)
[C78.6] Secondary malignant neoplasm of retroperitoneum and peritoneum (1)
[C79.89] Secondary malignant neoplasm of other specified sites (1)
[C80.0] Disseminated malignant neoplasm, unspecified (1)
[C80.1] Malignant (primary) neoplasm, unspecified (2)
[C80] Malignant neoplasm without specification of site (1)
[D72.0] Genetic anomalies of leukocytes (1)
[G62.82] Radiation-induced polyneuropathy (1)
[H05.32] Deformity of orbit due to bone disease (1)
[I42.7] Cardiomyopathy due to drug and external agent (1)
[I42] Cardiomyopathy (1)
[K86.9] Disease of pancreas, unspecified (1)
[M89.9] Metabollic Bone Disease (1)
[N39.0] Urinary Tract Infection (1)
[Z15.01] BRCA1 and BRCA2 Mutations (1)
[Z68.5] Body mass index (BMI) pediatric (1)

Procedures

[0003U] Measurement of proteins associated with ovarian cancer in serum (3)
[0005U] Test for detecting genes associated with prostate cancer in urine (3)
[0014U] DNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow (1)
[0022U] DNA and RNA gene analysis for non-small cell lung cancer (1)
[0030U] Gene analysis of targeted sequences for warfarin drug response (1)
[0036U] Exome gene analysis for somatic mutation in tumor tissue (1)
[0067U] Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue (1)
[00702] Anesthesia for liver biopsy (accessed through the skin) (1)
[00732] Anesthesia for diagnostic examination of gallbladder and pancreatic, liver, and bile ducts using an endoscope (2)
[0102U] Gene sequence analysis panel of 17 genes associated with hereditary breast cancer and related disorders (1)
[0131U] Targeted mRNA sequence analysis of 13 genes associated with hereditary breast cancer and related disorders (1)
[0166U] Liver disease test panel in serum specimen (1)
[0172U] DNA gene analysis (BRCA1, DNA repair associated and BRCA2, DNA repair associated) for detection of mutations associated with breast cancer (1)
[01922] Anesthesia for X-ray or radiation therapy (1)
[19294] Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal (2)
[19303] Mastectomy (1)
[28540] Closed treatment of ankle joint bone dislocation (1)
[28545] Closed treatment of ankle joint bone dislocation under anesthesia (1)
[48150] Whipple Procedure (2)
[49327] Examination of abdomen with insertion of devices for radiation therapy using endoscope (1)
[58210] Abdominal removal of uterus, cervix, and lymph nodes on both sides of pelvis and aortic lymph node biopsy (1)
[77261] Management of radiation therapy, simple (12)
[77262] Management of radiation therapy, intermediate (2)
[77263] Management of radiation therapy, complex (1)
[77427] Radiation Therapy (1)
[77799] Administration of radiation therapy (10)
[78815] Nuclear medicine study with CT imaging skull base to mid-thigh (1)
[81479] Molecular pathology procedure (1)
[87086] Bacterial colony count, urine (1)
[87088] Bacterial urine culture (1)
[87184] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (1)
[87186] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (1)
[96366] Infusion into a vein for therapy, prevention, or diagnosis (1)
[96377] Application of on-body injector for injection under skin (1)
[96401] Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle (3)
[96402] Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle (1)
[96405] Chemotherapy into a lesion, up to and including 7 lesions (2)
[96406] Chemotherapy into a lesion, more than 7 lesions (1)
[96409] Infusion of chemotherapy into a vein using push technique (2)
[99202] New patient outpatient visit, total time 15-29 minutes (1)
[99203] New patient outpatient visit, total time 30-44 minutes (1)
[99204] New patient outpatient visit, total time 45-59 minutes (1)
[99205] New patient outpatient visit, total time 60-74 minutes (1)
[99212] Established patient outpatient visit, total time 10-19 minutes (1)
[99213] Established patient outpatient visit, total time 20-29 minutes (1)
[99214] Established patient outpatient visit, total time 30-39 minutes (1)
[99215] Established patient outpatient visit, total time 40-54 minutes (1)

Showing 1 - 12 of 130 results

Previous| 1 | 2 | 3 ...11 |Next

New drug could double survival for eligible patients with pancreatic cancer

New drug could double survival for eligible patients with pancreatic cancer

About 90% of people with pancreatic cancer have pancreatic ductal adenocarcinoma (PDAC), which is driven by an activating mutation in the KRAS gene.

Adding drug to glioblastoma treatment may boost effectiveness

Adding drug to glioblastoma treatment may boost effectiveness

Study co-led by UTSW researchers could lead to new therapy for most common primary brain cancer

Live: The Future of Collaborative Cancer Care

Live: The Future of Collaborative Cancer Care

Jul 9, 2026 1:00 to 2:00 p.m. ET (Virtual Event)

First North Texas Patients Receive New Single-Port Robotic Surgery for Lung Cancer at UT Southwestern

First North Texas Patients Receive New Single-Port Robotic Surgery for Lung Cancer at UT Southwestern

The new single-port (SP) robotic approach at UT Southwestern is part of a broader precision thoracic oncology program that integrates advanced imaging, minimally invasive surgery, and multidisciplinary lung cancer care.

Ovarian cancer cells use stress hormone signaling to shut down immune system

Ovarian cancer cells use stress hormone signaling to shut down immune system

UTSW-led study provides insight into tumor microenvironment that could lead to more effective treatments

A New Era for NF1 – Advancing Care, Expanding Access

A New Era for NF1 – Advancing Care, Expanding Access

Why do people get brain tumors, and how can they be treated more effectively?

UTSW at 2026 ASCO Annual Meeting

UTSW at 2026 ASCO Annual Meeting

May 29 - June 2, 2026

Leadership Announcement: UT Southwestern Appoints New Director of Interventional Pulmonology

Leadership Announcement: UT Southwestern Appoints New Director of Interventional Pulmonology

We are pleased to announce the appointment of Laura Frye, M.D., as Director of Interventional Pulmonology at UT Southwestern Medical Center.

Study identifies why some breast cancers evade treatment

Study identifies why some breast cancers evade treatment

UTSW research links protein secreted by T cells to growth of hormone receptor-positive tumors

Type of KRAS mutation may guide more effective cancer treatments

Type of KRAS mutation may guide more effective cancer treatments

UTSW-led study shows that different mutations of the gene affect how tumors interact with the immune system

Two Trials, One Common Goal for Glioblastoma

Two Trials, One Common Goal for Glioblastoma

Glioblastoma remains one of the most aggressive and unforgiving diseases in medicine.

Pancreatic Cancer Symposium CME<br><sub>Dallas, TX US | April 18, 2026</sub>

Pancreatic Cancer Symposium CME
_{Dallas, TX US | April 18, 2026}

The UT Southwestern Pancreatic Cancer Symposium offers community cancer care specialists an opportunity to gain up-to-date, evidence-based insights on the evolving management of pancreatic cancer. As the only NCI-designated Comprehensive Cancer Center in North Texas, UT Southwestern Harold C. Simmons Comprehensive Cancer Center is committed to advancing education and expanding access to specialized care for this aggressive disease. This one-day live event will include topics such as molecular profiling and targeted therapeutics, minimally invasive and robotic surgical techniques, redefining the role of radiation therapy for pancreatic cancer, emerging systemic therapy strategies, and clinical trial opportunities for advanced disease and pancreatic neuroendocrine tumors.

Showing 1 - 12 of 130 results

Previous| 1 | 2 | 3 ...11 |Next

Powered by BROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty members have received six Nobel Prizes and include 28 members of the National Academy of Sciences, 26 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of nearly 3,400 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians in more than 80 specialties care for more than 143,000 hospitalized patients, attend to more than 470,000 emergency room cases, and oversee nearly 5.3 million outpatient visits a year.